Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting …
$0.98-4.98%
报价 2026-11-13
市值
$65.7M
EV
$85.2M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -65.7%
$0.94$2.85
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| MBOTMicrobot Medical Inc. | $65.7M | -5.0% | +4900.0% | -9.5% | – | – | – | |
| OVIDOvid Therapeutics Inc. | $479.4M | -0.4% | -87.9% | 100% | – | – | – | |
| RCELAVITA Medical, Inc. | $388.3M | -3.5% | – | 81.6% | – | – | – | |
| ORMPOramed Pharmaceuticals Inc. | $161.3M | -7.9% | -40.0% | 0% | 1.9x | 2.4x | – | |
| CRDLCardiol Therapeutics Inc. | $120.7M | -3.8% | – | 0% | – | – | – | |
| VANIVivani Medical, Inc. | $91.1M | +2.7% | -100.0% | 0% | – | – | – | |
| CLNNClene Inc. | $56.4M | -2.0% | +100.0% | -80.7% | – | – | – | |
| NSPRInspireMD, Inc. | $29.9M | -16.8% | – | 18.1% | – | – | – | |
| DCGODocGo Inc. | $20.6M | -7.7% | -3.5% | 30.1% | – | – | – | |
| 同行中位数 | – | – | -40.0% | 9% | 1.9x | 2.4x | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据(首次研究运行后填充)。
研究材料
Filing 摘要
电话会纪要摘要
暂无纪要摘要。